Response to: Khusid, Atallah, and Gupta re: "Metabolic Syndrome Negatively Impacts Stone-Specific Quality of Life" by Lim et al.

Indeed, the "Letter to the Editor" by Khusid and colleagues[1] has highlighted the difference in stone type between Metabolic Syndrome (MetS) and non-MetS patients - uric acid, cystine, and struvite stones being more common among MetS patients and calcium phosphate stones being more common among non-MetS patients. Reference 1 Khusid JA, Atallah WM, Gupta M. Editorial Comment on: Metabolic syndrome negatively impacts stone-specific quality of life. [Extracted from the article]